Perfusion predicts six-month survival

Article

Results from a prospective study bolster confidence that a negative adenosine perfusion contrast MR test means patients have a good chance of surviving the next six months without major heart problems.

Results from a prospective study bolster confidence that a negative adenosine perfusion contrast MR test means patients have a good chance of surviving the next six months without major heart problems.

Dr. David Hardung from St. Marien Hospital in Bonn, Germany, surveyed the medical experience of 432 patients with negative adenosine stress tests or evidence of minor perfusion deficits involving less than 25% transmural enhancement of the myocardial wall. The event-free survival rate after 267 days was 98.8%. One cardiac death was reported from nonischemic dilated cardiomyopathy. No incidences of myocardial infarction or acute coronary syndrome occurred, but four cases of significant coronary artery disease were identified among 36 patients who underwent coronary angiography in the follow-up period.

Recent Videos
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2025 MJH Life Sciences

All rights reserved.